Astek Diagnostics Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Astek Diagnostics Inc. - overview
Established
2020
Location
Baltimore, MD, US
Primary Industry
Medical Devices & Equipment
About
Based in Maryland, US, and founded in 2020, Astek Diagnostics Inc. provides medical devices used for the diagnosis of urinary tract infections (UTI). As of 2023, the company is headed by its CEO Mustafa Al-Adhami. In June 2025, Astek Diagnostics Inc.
raised USD 500,000 in pre-seed funding from returning investor TEDCO. The company offers Jiddu which is a benchtop diagnostic device that is made up of two distinct parts through microfluidics - a separation chamber and analyzer. The analyzer uses a single-use cartridge to identify bacterial infection in urine and then performs antibiotic susceptibility testing (AST) of the bacterium in one hour. The company plans to utilize the June 2025 funding to support and develop the upcoming generation of startup companies in the region.
Current Investors
Maryland Technology Development Corporation, Maryland Momentum Fund, Wexford SciTech Venture Fund
Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic Equipment
Website
www.astekdx.com
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.